Header Logo
  • VIICTR Profiles
  • ORIT
  • Pediatrics CRA
  • Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (4)
    • Congenital Hyperinsulinism
    • Defining the risks of mesenchymal stromal cell therapy.
    • Nicotine
    • Tibial Neuropathy
    • See All 4 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Defining the risks of mesenchymal stromal cell therapy.

Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 2010 Sep; 12(5):576-8.

View in: PubMed

subject areas
  • Adult Stem Cells
  • Animals
  • Biomarkers, Tumor
  • Cell Culture Techniques
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Cellular Senescence
  • Clinical Trials as Topic
  • Humans
  • Mesenchymal Stem Cell Transplantation
  • Mice
  • Risk Factors
  • Stromal Cells
  • Telomerase

authors with profiles
  • MALCOLM BRENNER